Loading...
XSESC2PU
Market cap1.75bUSD
Dec 20, Last price  
3.63SGD
1D
-0.55%
1Q
-11.25%
Jan 2017
53.81%
IPO
192.74%
Name

Parkway Life Real Estate Investment Trust

Chart & Performance

D1W1MN
XSES:C2PU chart
P/E
23.57
P/S
15.28
EPS
0.15
Div Yield, %
3.73%
Shrs. gr., 5y
Rev. gr., 5y
6.56%
Revenues
147m
+13.46%
16,900,00053,887,00066,679,00080,048,00087,763,00094,074,00093,693,000100,382,000102,694,000110,123,000109,881,000112,838,000115,222,000120,892,000120,705,000129,972,000147,467,000
Net income
100m
+144.23%
68,638,00024,696,00072,937,00065,052,000102,039,000115,411,00098,279,000121,106,00066,988,00091,929,000101,464,000151,932,000123,397,00087,224,000331,878,00041,136,000100,465,000
CFO
99m
+4.62%
12,215,00042,513,00055,007,00065,488,00066,812,00073,836,00076,433,00079,651,00082,013,00087,517,00080,746,00088,350,00089,248,00090,312,00089,862,00094,632,00099,001,000
Dividend
Aug 02, 20240.0754 SGD/sh
Earnings
Jan 30, 2025

Profile

Parkway Life Real Estate Investment Trust (“PLife REIT”) is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.
IPO date
Aug 23, 2007
Employees
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
147,467
13.46%
129,972
7.68%
120,705
-0.15%
Cost of revenue
24,574
24,195
24,805
Unusual Expense (Income)
NOPBT
122,893
105,777
95,900
NOPBT Margin
83.34%
81.38%
79.45%
Operating Taxes
7,803
7,081
8,874
Tax Rate
6.35%
6.69%
9.25%
NOPAT
115,090
98,696
87,026
Net income
100,465
144.23%
41,136
-87.61%
331,878
280.49%
Dividends
(88,391)
(64,312)
(85,184)
Dividend yield
3.98%
2.83%
2.74%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
53,559
56,650
94,733
Long-term debt
776,996
797,337
735,386
Deferred revenue
1,506
1,732
1,860
Other long-term liabilities
20,461
17,754
19,360
Net debt
802,056
779,549
788,431
Cash flow
Cash from operating activities
99,001
94,632
89,862
CAPEX
(31,036)
(63,891)
(11,692)
Cash from investing activities
(49,557)
(125,184)
(74,988)
Cash from financing activities
(67,919)
47,753
(9,981)
FCF
63,056
185,215
(219,578)
Balance
Cash
28,499
40,010
25,793
Long term investments
34,428
15,895
Excess cash
21,126
67,939
35,653
Stockholders' equity
585,258
3,021,460
3,046,851
Invested Capital
2,243,869
2,213,921
2,248,281
ROIC
5.16%
4.42%
4.12%
ROCE
5.34%
4.56%
4.13%
EV
Common stock shares outstanding
605,002
605,002
605,002
Price
3.67
-2.39%
3.76
-26.71%
5.13
32.22%
Market cap
2,220,357
-2.39%
2,274,808
-26.71%
3,103,660
32.22%
EV
3,022,413
3,866,235
4,694,305
EBITDA
122,893
105,777
95,922
EV/EBITDA
24.59
36.55
48.94
Interest
12,931
6,104
4,170
Interest/NOPBT
10.52%
5.77%
4.35%